Quest Diagnostics Total Long Term Liabilities 2010-2024 | DGX

Quest Diagnostics total long term liabilities from 2010 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.
  • Quest Diagnostics total long term liabilities for the quarter ending September 30, 2024 were $7.162B, a 32.61% increase year-over-year.
  • Quest Diagnostics total long term liabilities for 2023 were $5.865B, a 9.5% increase from 2022.
  • Quest Diagnostics total long term liabilities for 2022 were $5.356B, a 0.35% decline from 2021.
  • Quest Diagnostics total long term liabilities for 2021 were $5.375B, a 1.21% decline from 2020.
Quest Diagnostics Annual Total Long Term Liabilities
(Millions of US $)
2023 $5,865
2022 $5,356
2021 $5,375
2020 $5,441
2019 $5,166
2018 $4,251
2017 $4,491
2016 $4,459
2015 $4,076
2014 $3,818
2013 $3,843
2012 $4,050
2011 $4,037
2010 $3,259
2009 $3,493
Quest Diagnostics Quarterly Total Long Term Liabilities
(Millions of US $)
2024-09-30 $7,162
2024-06-30 $5,213
2024-03-31 $5,187
2023-12-31 $5,865
2023-09-30 $5,401
2023-06-30 $5,263
2023-03-31 $5,351
2022-12-31 $5,356
2022-09-30 $5,349
2022-06-30 $5,285
2022-03-31 $5,327
2021-12-31 $5,375
2021-09-30 $5,381
2021-06-30 $5,370
2021-03-31 $5,434
2020-12-31 $5,441
2020-09-30 $5,308
2020-06-30 $5,266
2020-03-31 $5,217
2019-12-31 $5,166
2019-09-30 $4,354
2019-06-30 $4,347
2019-03-31 $4,314
2018-12-31 $4,251
2018-09-30 $4,232
2018-06-30 $4,222
2018-03-31 $4,512
2017-12-31 $4,491
2017-09-30 $4,559
2017-06-30 $4,521
2017-03-31 $4,461
2016-12-31 $4,459
2016-09-30 $4,433
2016-06-30 $4,429
2016-03-31 $4,341
2015-12-31 $4,076
2015-09-30 $4,320
2015-06-30 $4,134
2015-03-31 $4,253
2014-12-31 $3,818
2014-09-30 $4,401
2014-06-30 $4,380
2014-03-31 $4,338
2013-12-31 $3,843
2013-09-30 $3,817
2013-06-30 $3,807
2013-03-31 $3,871
2012-12-31 $4,050
2012-09-30 $4,051
2012-06-30 $4,047
2012-03-31 $4,030
2011-12-31 $4,037
2011-09-30 $4,017
2011-06-30 $3,987
2011-03-31 $4,220
2010-12-31 $3,259
2010-09-30 $3,430
2010-06-30 $3,539
2010-03-31 $3,510
2009-12-31 $3,493
2009-09-30 $3,437
2009-06-30 $3,422
2009-03-31 $3,548
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $17.788B $9.252B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $20.419B 12.35
DaVita (DVA) United States $12.272B 15.87
Encompass Health (EHC) United States $10.397B 24.51
Chemed (CHE) United States $8.402B 25.82
Elanco Animal Health (ELAN) United States $6.955B 16.55
RadNet (RDNT) United States $5.364B 127.25
Option Care Health (OPCH) United States $3.826B 18.13
Amedisys (AMED) United States $3.166B 22.54
LifeStance Health (LFST) United States $2.816B 0.00
Addus HomeCare (ADUS) United States $2.313B 27.14
Astrana Health (ASTH) United States $2.305B 36.12
U.S Physical Therapy (USPH) United States $1.434B 37.73
Pennant (PNTG) United States $1.148B 46.42
Aveanna Healthcare Holdings (AVAH) United States $1.127B 0.00
Atai Life Sciences (ATAI) Germany $0.237B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.014B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.011B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00